Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Related
Stephen Saad’s wealth takes a hit as Aspen Pharmacare stock plunges, erasing $41 million
This downturn follows a $44 million gain in January, which had lifted his stake to R10.26 billion ($550.1 million).
Stephen Saad leads Africa’s largest drugmaker to $1.2 billion in half-year revenue
The growth was fueled by the successful integration of acquired products in Latin America.
Africa’s largest asset manager buys additional stake worth $67 million in Stephen Saad’s Aspen Pharmacare
With this latest transaction, PIC’s stake in Aspen is now worth nearly a billion dollars—R15.2 billion ($824.24 million).
South African pharma tycoon Stephen Saad’s Aspen stake rises above $550 million
With the recent rise in Aspen's stock price, the value of his holdings has crossed $550 million, marking a recovery after a challenging 2024.
Latest
Belayneh Kindie ventures into Ethiopia’s electric mobility space with 100 e-buses
Ethiopian businessman Belayneh Kindie launches 100 locally assembled electric buses in Addis Ababa, advancing Ethiopia’s clean transit and electric mobility goals.
Marvin Ellison, one of America’s Black executives, loses $21 million from Lowe’s stake
This decline follows earlier losses from Jan. 27 to Feb. 18, when his stake fell $12.44 million, from $200.78 million to $188.34 million.
Burkina Faso's richest man starts construction of Gabon's $370 million airport
EBOMAF has also been tapped to lead the development of Libreville 2 — a brand-new city designed for smart living and sustainable growth.
Arnaud Lagesse's Phoenix acquires $80 million stake in Seychelles Breweries from Diageo
The agreement strengthens the relationship between Diageo and Phoenix Beverages—a subsidiary of the Mauritius-based IBL Group.
